0.25Open0.25Pre Close0 Volume19 Open Interest12.50Strike Price0.00Turnover34.71%IV4.68%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.3935Delta0.4100Gamma48.72Leverage Ratio-0.0107Theta0.0022Rho19.17Eff Leverage0.0104Vega
Indivior Stock Discussion
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...
No comment yet